Trade Summary

2 days ago, Garrison Michael David, serving as EVP & Pres Med.Essntl&BioPharm at BECTON DICKINSON & CO (BDX), sold 1,100 shares at $145.66 per share, for a total transaction value of $160,226.00. Following this transaction, Garrison Michael David now holds 13,172 shares of BDX.

This sale represents a 7.71% decrease in Garrison Michael David's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, June 24, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 25, 2026 at 10:16 AM ET, 1 day after the trade was made.

BECTON DICKINSON & CO operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.